Pd-Rx Pharmaceutical is trading at 3.33 as of the 5th of February 2026; that is No Change since the beginning of the trading day. The stock's open price was 3.33. Pd-Rx Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 7th of November 2025 and ending today, the 5th of February 2026. Click here to learn more.
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. The company has 1.72 M outstanding shares. More on Pd Rx Pharmaceutical
Pd Rx Pharmaceutical [PDRX] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pd-Rx Pharmaceutical's market, we take the total number of its shares issued and multiply it by Pd-Rx Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pd Rx Pharmaceutical conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 1.72 M outstanding shares.
Pd Rx Pharmaceutical currently holds about 104.55 K in cash with (465.77 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Pd-Rx Pharmaceutical Probability Of Bankruptcy
The company last dividend was issued on the 13th of December 2018. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.The quote for Pd Rx Pharmaceutical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pd Rx Pharmaceutical contact RPh DO at 405 942 3040 or learn more at https://www.pdrx.com.
Pd Rx Pharmaceutical Investment Alerts
Pd Rx Pharmaceutical currently holds about 104.55 K in cash with (465.77 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Pd-Rx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pd-Rx Pharmaceutical's market, we take the total number of its shares issued and multiply it by Pd-Rx Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Pd-Rx Profitablity
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.
Technical Drivers
As of the 5th of February, Pd-Rx Pharmaceutical owns the market risk adjusted performance of 7.76, and Information Ratio of 0.1159. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of Pd Rx Pharmaceutical, as well as the relationship between them.
The output start index for this execution was zero with a total number of output elements of sixty-one. Pd Rx Pharmaceutical Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Pd-Rx Pharmaceutical price patterns.
Pd-Rx Pharmaceutical Outstanding Bonds
Pd-Rx Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pd Rx Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pd-Rx bonds can be classified according to their maturity, which is the date when Pd Rx Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Pd-Rx Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pd-Rx Pharmaceutical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Pd-Rx Pharmaceutical's time-series forecasting models are one of many Pd-Rx Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pd-Rx Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Pd-Rx Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Premium Stories Now
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.